Oculis Holding AG (OCS) Return on Assets (2023 - 2026)
Oculis Holding AG (OCS) recorded quarterly Return on Assets of 0.69% in Q1 2026, up 16.77% quarter-over-quarter from 0.83% in Q4 2025, and up 59.0% on a YoY basis from 0.44% in Q1 2025.
Oculis Holding AG (OCS) Return on Assets (2023 - 2026) Analysis & Trends
Oculis Holding AG's Return on Assets history runs 4 years deep, the most recent figure standing at 0.69% for Q1 2026.
- In Q1 2026, Return on Assets rose 59.0% year-over-year to 0.69%; the TTM figure through Mar 2026 stood at 0.69% (up 59.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets was 0.69% for Q1 2026 at Oculis Holding AG, up from 0.83% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2024 to a low of 1.65% in Q4 2024.
- Historically, Return on Assets has averaged 0.73% across 4 years, with a median of 0.83% in 2025.
- The sharpest annual moves came in 2024 and 2025: Return on Assets slumped 165 bps in 2024, then jumped 82 bps in 2025.
- A 4-year view of Return on Assets shows it stood at 0.01% in 2023, then tumbled by 23167 bps to 1.65% in 2024, then surged by 50 bps to 0.83% in 2025, then climbed by 17 bps to 0.69% in 2026.
- The last three Return on Assets figures came in at 0.69% (Q1 2026), 0.83% (Q4 2025), and 0.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -0.01% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.01% |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | -0.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.69% |
| Dec 31, 2025 | -0.83% |
| Sep 30, 2025 | -0.99% |
| Jun 30, 2025 | -1.05% |
| Mar 31, 2025 | -1.28% |
| Dec 31, 2024 | -1.65% |
| Sep 30, 2024 | -1.56% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |